Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 72, 65-81

Vaccines Against Bacterial Meningitis


Vaccines Against Bacterial Meningitis

S Segal et al. Br Med Bull.


Meningitis remains an important cause of morbidity and mortality among children >5 years of age and is especially prevalent in developing countries. Effective routine immunization against Hib, pneumococcus and serogroupC meningococcus has had a significant impact on both invasive disease and carriage caused by these encapsulated bacteria. The major challenge in prevention of meningitis remains the delivery of vaccines worldwide, especially to resource-poor regions with the greatest disease burden.

Similar articles

  • Prevention of Bacterial Meningitis. Vaccines and Chemoprophylaxis
    JM Lieberman et al. Infect Dis Clin North Am 4 (4), 703-29. PMID 2126022. - Review
    The morbidity and mortality caused by bacterial meningitis remains significant despite advances in antimicrobial therapy and supportive care. Prevention of meningitis by …
  • Progress Towards Meningitis Prevention in the Conjugate Vaccines Era
    CA Laval et al. Braz J Infect Dis 7 (5), 315-24. PMID 14552741. - Review
    Acute bacterial meningitis is an important cause of morbidity and mortality among children less than five years old, Haemophilus influenzae, Streptococcus pneumoniae and …
  • The Implications of Vaccines for Prevention of Bacterial Meningitis
    A Riordan. Curr Opin Neurol 23 (3), 319-24. PMID 20173637. - Review
    Great progress has been made in developing vaccines that prevent meningitis. The remaining challenges are to introduce vaccines with broad protection against meningococci …
  • Bacterial Meningitis: The Impact of Vaccination
    N Makwana et al. CNS Drugs 21 (5), 355-66. PMID 17447825. - Review
    Acute bacterial meningitis remains an important cause of morbidity and mortality in children. Children <2 years of age are particularly susceptible to infection with e …
  • New Aspects of Prevention and Therapy of Meningitis
    SL Kaplan. Infect Dis Clin North Am 6 (1), 197-214. PMID 1578118. - Review
    Cefotaxime and ceftriaxone are currently the agents of first choice for empiric treatment of bacterial meningitis in children. Further studies are necessary to determine …
See all similar articles

Cited by 7 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources